Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Quarterly results
|
|
22nd Century Group, Inc. (XXII)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/14/2023 |
8-K
| Quarterly results|
Docs:
|
"CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “..." |
|
| 07/24/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte...|
Docs:
|
"Form of Warrant",
"Opinion of Foley & Lardner LLP",
"Form of Securities Purchase Agreement, by and between 22nd Century Group, Inc. and each of the Purchasers (as defined therein)",
"22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market BUFFALO, N.Y., July 6, 2023 -- 22nd Century Group, Inc. , a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has entered into definitive agreements with certain investors for the purchase and sale of 778,634 shares of common stock and warrants at a price of $3.80 per share in a registered direct offering priced above market. Gross proceeds to the Company from the registered direct offering are expected to be $3.0 million, before deducting the placement agent’ s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from this offering for the conti..." |
|
| 05/09/2023 |
8-K
| Quarterly results|
Docs:
|
"CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “..." |
|
| 04/21/2023 |
8-K
| Quarterly results |
| 04/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat... |
| 03/31/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 03/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 03/09/2023 |
8-K
| Quarterly results|
Docs:
|
"Revenues, net $ 19,206 $ 7,960 $ 62,111 $ 30,948 Cost of goods sold 19,852 7,729 60,937 29,462 Gross profit 231 1,174 1,486 Operating expenses: Sales, general and administrative 14,097 8,058 44,517 25,908 Research and development 2,093 1,126 6,561 3,912 Other operating expense, net 6,322 78 7,202 78 Total operating expenses 22,512 9,262 58,280 29,898 Operating loss Other income : Unrealized loss on investments — Realized gain on Panacea investment — 2,548 Realized loss on short-term investment securities — — Other income, net 15 — 71 — Interest income, net 102 49 313 321 Interest expense Total other expense Loss before income taxes provision for income taxes 2,148 14 14 Net loss $ $ $ $ Net loss per common share - basic and diluted $ $ $ $ Weighted average common shares outstandin...",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “..." |
|
| 01/24/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 11/21/2022 |
8-K
| Quarterly results |
| 11/17/2022 |
8-K
| Quarterly results |
| 11/08/2022 |
8-K
| Quarterly results|
Docs:
|
"CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE",
"CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTSThis presentation contains forward-looking statements concerning our business operations, and financial performance and conditions, as well as our plans, objectives, and expectations for our business operations and financial performance and conditions that are subject to risks and uncertainties. All statements other than those of historical fact are forward-looking statements. These types of statements typically contain words such as “aim,” “anticipate,” “assume,” “believe,” “could,” “due,” “estimate,” “expect,” “goal,” “intend,” “may,” “objective,” “plan,” “p..." |
|
| 09/12/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/07/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/09/2022 |
8-K
| Quarterly results |
| 07/25/2022 |
8-K
| Quarterly results |
| 06/21/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
8-K
| Quarterly results |
| 05/18/2022 |
8-K
| Quarterly results |
| 05/05/2022 |
8-K
| Quarterly results |
| 03/01/2022 |
8-K
| Quarterly results |
| 01/21/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/23/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 11/19/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/04/2021 |
8-K
| Quarterly results |
| 08/19/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/05/2021 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"22nd Century Group to Begin Trading on Nasdaq on August 16, 2021 BUFFALO, N.Y., August 5, 2021 – 22nd Century Group, Inc. , a leading plant-based, biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that its common stock has been approved for uplisting to the Nasdaq Capital Market effective as of the market open on August 16, 2021. The shares will continue to trade under the ticker symbol “XXII.” “While remaining dedicated to our primary mission to reduce the harm caused by smoking, uplisting to the Nasdaq also aligns 22nd Century with other high-achieving, innovative, and growth-oriented global science and technology companies,” said James A. Mish, chief executive officer of 22nd Century Group. “We believe that joi..." |
|
| 08/05/2021 |
8-K
| Quarterly results |
| 07/02/2021 |
8-K
| Quarterly results |
| 06/07/2021 |
8-K
| Quarterly results |
| 05/21/2021 |
8-K
| Quarterly results |
| 05/06/2021 |
8-K
| Quarterly results |
|
|
|